D'Souza A - Search Results

1

Rizio AA, White MK, D'Souza A, Hsu K, Schmitt P, Quock TP, Signorovitch J, Lousada I, Sanchorawala V. Rizio AA, et al. Patient Relat Outcome Meas. 2023 May 18;14:153-169. doi: 10.2147/PROM.S399658. eCollection 2023. Patient Relat Outcome Meas. 2023. PMID: 37229285 Free PMC article. Review.

2

Mortality and healthcare costs in Medicare beneficiaries with AL amyloidosis.

Quock TP, Chang E, Munday JS, D'Souza A, Gokhale S, Yan T. Quock TP, et al. J Comp Eff Res. 2018 Nov;7(11):1053-1062. doi: 10.2217/cer-2018-0062. Epub 2018 Oct 25. J Comp Eff Res. 2018. PMID: 30354284 Free article.

3

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States.

Quock TP, Yan T, Tieu R, D'Souza A, Broder MS. Quock TP, et al. Clinicoecon Outcomes Res. 2019 Jul 15;11:431-439. doi: 10.2147/CEOR.S207127. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31410040 Free PMC article.

4

Diagnostic amyloid light chain amyloidosis hospitalizations associated with high acuity and cost: analysis of the Premier Healthcare Database.

D'Souza A, Broder MS, Bognar K, Chang E, Tarbox MH, Quock TP. D'Souza A, et al. J Comp Eff Res. 2022 Dec;11(17):1225-1230. doi: 10.2217/cer-2022-0141. Epub 2022 Oct 21. J Comp Eff Res. 2022. PMID: 36268951 Free article.

5

In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database.

Quock TP, D'Souza A, Broder MS, Bognar K, Chang E, Tarbox MH. Quock TP, et al. J Comp Eff Res. 2023 Feb;12(2):e220185. doi: 10.2217/cer-2022-0185. Epub 2022 Dec 7. J Comp Eff Res. 2023. PMID: 36476016 Free PMC article.

6

Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy.

Chakraborty R, Zanwar S, Hegenbart U, Bhutani D, Gertz MA, Dispenzieri A, Kumar S, D'Souza A, Patwari A, Cowan A, Chen G, Milani P, Palladini G, Sanchorawala V, Bodanapu G, Schönland SO, Lentzsch S, Muchtar E. Chakraborty R, et al. Blood. 2024 Dec 19;144(25):2613-2624. doi: 10.1182/blood.2024025899. Blood. 2024. PMID: 39197073

7

A cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis.

D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE. D'Souza A, et al. Qual Life Res. 2023 Jun;32(6):1807-1817. doi: 10.1007/s11136-023-03354-9. Epub 2023 Feb 4. Qual Life Res. 2023. PMID: 36738402 Free PMC article.

8

Surgical Management of Breast Amyloidosis.

Bacos JT, Doren E, D'Souza A, Jorns J, Kong A. Bacos JT, et al. Clin Breast Cancer. 2023 Aug;23(6):e359-e367. doi: 10.1016/j.clbc.2023.06.001. Epub 2023 Jun 16. Clin Breast Cancer. 2023. PMID: 37357131 Review.

9

Differences in patient-reported outcomes (PROs) by disease severity in light chain (AL) amyloidosis.

D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE. D'Souza A, et al. Eur J Haematol. 2023 Oct;111(4):536-543. doi: 10.1111/ejh.14036. Epub 2023 Jul 3. Eur J Haematol. 2023. PMID: 37401100 Free PMC article.

10

Development and initial validation of the AL-PROfile patient-reported outcome measure in light chain (AL) amyloidosis.

D'Souza A, Szabo A, Akinola I, Finkel M, Flynn KE. D'Souza A, et al. Eur J Haematol. 2024 Jun;112(6):900-909. doi: 10.1111/ejh.14183. Epub 2024 Feb 13. Eur J Haematol. 2024. PMID: 38350661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

931 results

Search Page

Filters